癌细胞中的铁死亡抗性:用于联合治疗的纳米颗粒作为一种解决方案。

Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution.

作者信息

Adzavon Kodzo Prosper, Zhao Weijian, He Xuesong, Sheng Wang

机构信息

College of Chemistry and Life Science, Beijing University of Technology, Beijing, China.

出版信息

Front Pharmacol. 2024 Jun 19;15:1416382. doi: 10.3389/fphar.2024.1416382. eCollection 2024.

Abstract

Ferroptosis is a form of regulated cell death (RCD) characterized by iron-dependent lipid peroxidation. Ferroptosis is currently proposed as one of the most promising means of combating tumor resistance. Nevertheless, the problem of ferroptosis resistance in certain cancer cells has been identified. This review first, investigates the mechanisms of ferroptosis induction in cancer cells. Next, the problem of cancer cell resistance to ferroptosis, as well as the underlying mechanisms is discussed. Recently discovered ferroptosis-suppressing biomarkers have been described. The various types of nanoparticles that can induce ferroptosis are also discussed. Given the ability of nanoparticles to combine multiple agents, this review proposes nanoparticle-based ferroptosis cell death as a viable method of circumventing this resistance. This review suggests combining ferroptosis with other forms of cell death, such as apoptosis, cuproptosis and autophagy. It also suggests combining ferroptosis with immunotherapy.

摘要

铁死亡是一种受调控的细胞死亡(RCD)形式,其特征在于铁依赖性脂质过氧化。目前,铁死亡被认为是对抗肿瘤耐药性最有前景的手段之一。然而,已发现某些癌细胞存在铁死亡抗性问题。本综述首先研究癌细胞中铁死亡诱导的机制。接下来,讨论癌细胞对铁死亡的抗性问题及其潜在机制。还描述了最近发现的铁死亡抑制生物标志物。同时也讨论了可诱导铁死亡的各种类型的纳米颗粒。鉴于纳米颗粒能够结合多种药物,本综述提出基于纳米颗粒的铁死亡细胞死亡是规避这种抗性的可行方法。本综述建议将铁死亡与其他形式的细胞死亡相结合,如凋亡、铜死亡和自噬。它还建议将铁死亡与免疫疗法相结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94fb/11219589/397e3ca00443/fphar-15-1416382-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索